|
Draetta, G., Brizuela, L., Potashkin, J. and Beach, D. 1987. Identification
of p34 and p13, human homologs of the cell cycle regulators of fission
yeast encoded by cdc2 and suc1. Cell 50, 319-325.
Brizuela, L. , Draetta, G. and Beach, D. 1987. p13suc1 acts in the fission
yeast cell division cycle as a component of the p34cdc2 protein kinase.
EMBO J. 6 (11), 3507-3514.
Dunphy, W., Brizuela, L., Beach, D. and Newport, J. 1988. Xenopus cdc2
protein kinase is a component of MPF. Cell 54, 423-431.
Draetta, G., Brizuela, L. and Beach, D. 1988. p34 protein kinase, a human
homolog of the yeast cell cycle control proteins encoded by cdc2 and cdc28.
In Cancer Cells 6. T. Kelli and B. Stillman (eds). CSHL,
Cold Spring Harbor, NY.
Brizuela, L., Draetta, G. and Beach, D. 1988. Physical association between
the products of cdc2 and suc1 genes of fission yeast and their homologs
in mammalian cells. In Nuclear Oncogenes. E. Harlow (ed.).
CSHL, Cold Spring Harbor, NY.
Arion, D., Meijer, L., Brizuela, L. and Beach, D. 1988. cdc2 homolog
is a subunit of the M phase-specific histone H1 kinase of starfish meiotic
oocytes. Cell 55, 371-378.
Draetta, G., Luca, F., Westendorf, J., Brizuela, L., Ruderman, J. and
Beach, D. 1988. Interaction of the cdc2 kinase with cyclins. Cell
56, 829-838.
Draetta G., Brizuela L., Beach D. 1988. p34, a protein kinase involved
in cell cycle regulation in eukaryotic cells. Adv Exp Med Biol
231:453-457.
Brizuela, L. , Draetta, G. and Beach, D. 1989. Activation of cdc2 as
a histone H1 kinase is associated with complex formation with the p62
subunit. PNAS 86, 4362-4366.
Riabowol, K., Draetta, G., Brizuela, L., Vandre, L. and Beach, D. 1989.
The cdc2 kinase is a nuclear protein that is essential for mitosis in
mammalian cells. Cell 57, 394-401.
Meijer, L., Arion, D., Goldsteyn, R., Pines, J., Brizuela, L., Hunt,
T. and Beach, D. 1989. Cyclin is a subunit of the sea urchin M-phase specific
histone H1 kinase. EMBO J. 6 (11), 3507-3514.
Mc Vey, D., Brizuela, L., Mohr, I, Marshak, D., Gluzman, Y. and Beach,
D. 1990. Phosphorylation of T antigen by cdc2 stimulates SV40 DNA replication.
Nature 341, 503-507
Luscher, B., Brizuela, L., Beach, D. and Eisenman. R. 1991. A role for
the p34cdc2 kinase and phosphatases in the regulation of phosphorylation
and disassembly of lamin B2 during the cell cycle. EMBO 10 (4),
865-876.
Weiderrecht, G., Brizuela, L., Elliston, K., Nolan, S. and Siekierka,
J. 1991. FKB1 encodes a nonessential FK506-binding protein in S. cerevisiae
and contains a region suggesting homology to the cyclophilins.PNAS
88, 1029-1033.
Brizuela, L., Chrebet, G., Bostian, K. and Parents, S. 1991. Antifungal
propierties of the immunosuppressor FK-506: Identification of an FK-506
responsive yeast gene distinct from FKB1. MCB 11 (9), 4616-4626.
Neilsen, J., Foor, F, Siekierka, J., Hsu, M., Ramadan, N., Morin, N.,
Shafiee, A., Dhal, A., Brizuela, L. , Chrebet, G , Bostian, K. and Parents,
S. 1992. The yeast FKBP-13 is membrane associated FK506-binding protein
encoded by the nonessential gene FKB2. PNAS 89, 7471-75.
Sigal, N., Dumont, F., Siekierka, J., Wiederrecht, G., Parents, S. and
Brizuela, L. 1992. Is FKBP involved in the immunosuppresive and/or toxic
mechanism of action of FK506 ?. Transplant. Proc. 23, 2846-2849.
Brizuela, L., Ulug, T., Jones, M. and Courtneidge, S. 1995. Induction
of Il2 transcription by the hamster polyomavirusmiddle T antigen : a role
for Fyn in T cell signal transduction. Eur. J. Immunol. 25, 385-393.
Wick, S., Dubay, M., Imanil, I. and Brizuela, L. 1995. Biochemical and
mutagenic analysis of the melanoma tumor suppressor gene product/p16.
Oncogene: 11, 2013-2019.
Carlson, B.A., Dubay, M.M., Sausville, E.A., Brizuela, L. and Worland,
P.J. 1996. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent
kinase (cdk) 2 and cdk4 in human breast carcinoma cells. Cancer Res.:
56, 2973-2978.
Lamphere, L., Fiore, F., Keezer, S., Brizuela, L., Draetta, G and Gyuris,
J. 1997. Interaction between Cdc37 and Cdk4 in human cells. Oncogene:
14, 1999-2004.
Luh, F. Y., Archer, S. J., Domaille, P. J., Smith, B. O., Owen, D.,
Brotherton, D. H., Raine, A. R.C., Xu, X., Brizuela L.?, Brenner S. and
Laue E. D. 1997. Structure of the Cyclin Dependent Kinase Inhibitor p19INK4d.
Nature: 389, 999-1002.
Brotherton D.H., Dhanaraj V., Wick S., Brizuela L., Domaille P.J., Volyanik
E., Xu X., Parisini E., Smith B.O., Archer S.J., Serrano M., Brenner S.L.,
Blundell T.L., Laue E.D. 1998. Crystal structure of the complex of the
cyclin D-dependent kinase Cdk6 bound to the
cell-cycle inhibitor p19INK4d. Nature: 395, 244-50
Xu,X., Nakano, T., Wick, S. Dubay, M. and Brizuela, L. 1999. Mechanism
of CDK2/cyclin E inhibition by p27 and p27 phosphorylation. Biochemistry
38, 8713-22
Brizuela, L., Gyuris, J. and Mansuri, M. 2000. Cyclin Dependent Kinases
and their Regulators as Potential Targets for Anticancer Therapeutics.
In Principles of Molecular Oncology. Bronchud, M (ed). Human
Press Inc. NJ.
Murthy, K., Dubay, M., McClure, C., Brizuela, L., Boisclair, M., Worland,
P., Manzuri, M. and Pall, K. 2000. Cyclin dependent Kinase inhibitory
activity of Flavopiridol analogs. Bioorg. & Medic. Chem. Lett.
10:1037-1041
Strack, P., Caliguri M., Pelletier, M., Boisclair, M., Theodoras, A.,
Beer-Romero, P., Glass, S., Parsons, T., Copeland, R.A., Auger, K., Bendfield,
P., Brizuela, L. and Rolfe, M. 2000. SCF?TRCP and phosphorylation dpendent
ubiquitination of IkB??is catalyzed by Ubc3 and Ubc4. Oncogene.
19: 3529-3536.
Brizuela, L., Braun, P. And Labaer, J. 2001. FLEXGene repository: from
sequenced genomes to gene repositories for high-throughput functional
biology and proteomics. Mol. Bioch. Parasit 118:155-65.
Carini DJ, Kaltenbach RF, Liu J, Benfield PA, Boylan J, Boisclair M,
Brizuela L, Burton CR, Cox S, Grafstrom R, Harrison BA, Harrison K, Akamike
E, Markwalder JA, Nakano Y, Seitz SP, Sharp DM, Trainor GL, Sielecki TM.
2001. Identification of selective inhibitors of cyclin dependent kinase
4. Bioorg Med Chem Lett 11:2209-11
Brizuela, L., Richardson, A., Marsischky, G and LaBaer, J. 2002. Exploiting
the fruits of the genome sequencing projects by creating a needed resource
to face the challenges of the post-genomic era. Arch. Med. Res.33:318-324.
|